Next Article in Journal
5'-Chloro-5'-deoxy-(±)-ENBA, a Potent and Selective Adenosine A1 Receptor Agonist, Alleviates Neuropathic Pain in Mice Through Functional Glial and Microglial Changes without Affecting Motor or Cardiovascular Functions
Previous Article in Journal
On the Catalytic Effect of Water in the Intramolecular Diels–Alder Reaction of Quinone Systems: A Theoretical Study
Due to scheduled maintaince work on one of the switches in our server center, our websites and may experience short service dirsuptions of up to 5 minutes on 30 January 2015 00:00 PM EST time.
Molecules 2012, 17(12), 13704-13711; doi:10.3390/molecules171213704

An Electrostatically Crosslinked Chitosan Hydrogel as a Drug Carrier

, 1
, 2
, 2
 and 2,*
Received: 17 October 2012 / Revised: 9 November 2012 / Accepted: 12 November 2012 / Published: 22 November 2012
(This article belongs to the Section Organic Synthesis)
Download PDF [642 KB, updated 18 June 2014; original version uploaded 18 June 2014]
Abstract: Considerable efforts have been devoted to control and maintain the sustained release of proteins. In this experiment, we used bovine serum albumin-fluorescein isothiocyanate (BSA-FITC) as a model protein to explore the potential utility of a chitosan and glycerol phosphate disodium salt (GP) hydrogel as a protein drug depot. The mixing of chitosan and GP solutions (0, 10, 20 and 30 wt%) formed a liquid at room temperature. At 37 °C, however, the chitosan/GP solutions formed hydrogels through an electrostatic crosslinking process. This electrostatic interaction between the chitosan, cationic amine group, and GP, anionic phosphate group, was confirmed by the changes of zeta potentials and particle sizes of this solution. The electrostatic interaction depended both on the GP ratios in chitosan and the incubation time of chitosan/GP solutions. Furthermore, BSA-FITC-loaded chitosan/GP hydrogels were examined for their ability as potential depots for the BSA drugs. Hence, when observed, the BSA-FITC-loaded chitosan/GP hydrogels showed an in vitro sustained release profile of BSA up to 14 days. Collectively, our results show that the chitosan/GP hydrogels described here, can serve as depots for BSA drugs.
Keywords: chitosan; glycerol phosphate disodium salt; hydrogel; protein; depot chitosan; glycerol phosphate disodium salt; hydrogel; protein; depot
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |

MDPI and ACS Style

Kim, G.O.; Kim, N.; Kim, D.Y.; Kwon, J.S.; Min, B.-H. An Electrostatically Crosslinked Chitosan Hydrogel as a Drug Carrier. Molecules 2012, 17, 13704-13711.

AMA Style

Kim GO, Kim N, Kim DY, Kwon JS, Min B-H. An Electrostatically Crosslinked Chitosan Hydrogel as a Drug Carrier. Molecules. 2012; 17(12):13704-13711.

Chicago/Turabian Style

Kim, Ga O.; Kim, Nawoo; Kim, Da Y.; Kwon, Jin S.; Min, Byoung-Hyun. 2012. "An Electrostatically Crosslinked Chitosan Hydrogel as a Drug Carrier." Molecules 17, no. 12: 13704-13711.

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert